Politics

Meet the NFF: New Group to Lobby Trump, Congress on Cannabis

Published on March 22, 2017 · Last updated July 28, 2020
Empty vintage congress hall with seats and microphones.

Several leading cannabis companies across the United States have banded together to form a political advocacy group aimed at protecting the legal cannabis trade. The group includes major mainstream cannabis players and a long-established brand that’s a newcomer to the cannabis space.

The new group, called the New Federalism Fund (NFF), is being backed by these companies:

  • Scotts Company LLC, a subsidiary of the Scotts Miracle-Gro Co., a lawn and garden company that has been recently investing a lot of money in the cannabis market.
  • Colorado retail cannabis chains LivWell Enlightened Health, Medicine Man, and Native Roots
  • Multistate infused products maker Dixie Brands
  • International cannabis investment firm Privateer Holdings (which owns Leafly)
  • Arizona-based Tryke Companies, a medical cannabis company that operates Reef Dispensaries in Nevada and Arizona

The NFF will have three primary aims: continuing the smooth operation of a regulated industry in states that have legalized medical or recreational marijuana; maintaining the federal government’s hands-off approach toward cannabis when it comes to law enforcement; and reforming the 280E section of the federal tax code.

The NFF was created 'to have positive engagement with Congress and the Trump administration.'

Leafly reached out to Medicine Man, Native Roots, Privateer Holdings, and Dixie Brands. They declined to comment on the story. We were able to reach NFF Chairman Neal Levine, however, who said the group plans to work with Congress and the Trump administration to achieve its goals.

“The organization was created to have positive engagement with Congress and the Trump administration,” said Levine, a board member of the National Cannabis Industry Association (NCIA) and director of government affairs for LivWell Enlightened Health. “If you listen to some of the negative comments coming out of the Department of Justice and the White House, about who we are and what we’re doing, it’s pretty apparent that there’s a lot of misinformation.”

Sharing Similar Goals

“Our industry aligns with some of the administration’s goals,” Levine said. “They have clearly said they want to crack down on drug cartels. They want to engage in substantial infrastructure projects and do comprehensive tax reform.” The legal, state-regulated industry effectively eliminates most of the black market that supports the drug cartels. And on tax reform, “we have this terrible tax penalty, 280E, which effectively functions as an 80% or 90% tax rate on cannabis businesses.”

“We can all agree on one concept: Marijuana is here and it is popular,” Levine said. “We can all agree that someone is going to sell it. And therefore, our industry is the answer. Who do you want selling this product? Do you want transparent, regulated, legally compliant companies that don’t allow anyone under the age of 21 into their store? Who test all their products? Who work with their regulators and work with their state, and pay their taxes? Or do you want drug cartels that don’t test their product and will sell to anyone? Someone is going to sell this. It’s a binary choice: Do you want drug dealers to sell or do you want regulated businesses?

“We feel like we are the solution to [the issues that the Trump administration and Congress] are talking about.”

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Leafly Staff
Leafly Staff
Leafly is the world’s largest cannabis information resource, empowering people in legal cannabis markets to learn about the right products for their lifestyle and wellness needs. Our team of cannabis professionals collectively share years of experience in all corners of the market, from growing and retail, to science and medicine, to data and technology.
View Leafly Staff's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.